Quantitative analysis of endosomal escape and intracellular delivery via bioorthogonal luminescent reaction
BioLure aims to revolutionize intracellular delivery quantification using a bioorthogonal luminescent reaction for high-throughput assessment of endosomal escape in live cells.
Projectdetails
Introduction
Intracellular delivery of membrane-impermeable biomacromolecules is essential for a broad spectrum of life sciences, ranging from fundamental biological studies to applied biomedical and pharmaceutical sciences. Despite the great efforts in developing new intracellular delivery nanocarriers in the recent 20 years, simple, high-throughput, and accurate intracellular delivery quantification in live cells is still technically challenging.
Proposed Methodology
In BioLure, I propose an unconventional approach to quantify intracellular delivery and endosomal escape by a bioorthogonal luminescent reaction in live cells. Instead of a bulky fluorophore, I will label the molecule of interest (MOI) to be delivered with a single amino acid tag, which causes minimal changes in MOI’s physicochemical properties and functions.
Mechanism of Action
The tag will generate luciferase substrate inside live cells upon successful translocation into the cytoplasm by bioorthogonal reactions with:
- Chemoselectivity
- Rapid kinetics
- Biocompatibility
- High efficiency
Application and Validation
The quantification strategy will initially be applied to the intracellular delivery of proteins via physical membrane disruption and validated by complementary methods. It will then be expanded to nanocarrier-mediated endosomal escape with different MOIs, including therapeutic siRNAs. The successful endosomal escape quantification will allow further nanoparticle screening for siRNA delivery.
Future Implications
I envision that BioLure will lead to a paradigm shift in the intracellular delivery field, facilitating the transformation from qualitative routine fluorescence imaging to high-throughput real-time quantification.
Benefits for Researchers
The high sensitivity and low background make it an appealing tool for:
- Biologists to study endosomal escape
- Material scientists to develop potent next-generation non-viral intracellular nanocarriers
Ultimately, it will facilitate the design and screening of endosomal escape carriers and future nanomedicine formulations.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.488.074 |
Totale projectbegroting | € 1.488.074 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 31-12-2028 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- HELSINGIN YLIOPISTOpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Time-based single molecule nanolocalization for live cell imagingThe project aims to develop a novel live-cell nanoscopy technique that enables high-speed, high-resolution imaging of biological processes at the nanoscale without compromising depth or volume. | ERC Advanced... | € 2.498.196 | 2023 | Details |
Bioorthogonal Cascade-Targeting: Directing Drugs into Cells with Molecular PrecisionDevelop bioorthogonal cascade-targeting methods for precise, safe, and efficient intracellular delivery of therapeutics, enhancing drug targeting and minimizing collateral damage. | ERC Starting... | € 1.479.321 | 2023 | Details |
Engineering lipid nanoparticles to target and escape the endosome, deliver their cargo and perform better as breast cancer therapiesThis project aims to enhance LNP-mRNA nanomedicine efficacy for advanced breast cancer by improving endosomal escape through nanoscale engineering and tailored formulations. | ERC Starting... | € 1.844.248 | 2024 | Details |
Linker molecules convert commercial fluorophores into tailored functional probes during biolabelingThe project aims to enhance the performance of fluorescent probes by developing versatile linker compounds that improve labeling properties for biomedical applications, reducing costs and increasing reliability. | ERC Proof of... | € 150.000 | 2024 | Details |
Single-Molecule Acousto-Photonic NanofluidicsSIMPHONICS aims to develop a high-throughput, non-invasive platform for protein fingerprinting by integrating nanopore technology with acoustic manipulation and fluorescence detection. | ERC Starting... | € 1.499.395 | 2022 | Details |
Time-based single molecule nanolocalization for live cell imaging
The project aims to develop a novel live-cell nanoscopy technique that enables high-speed, high-resolution imaging of biological processes at the nanoscale without compromising depth or volume.
Bioorthogonal Cascade-Targeting: Directing Drugs into Cells with Molecular Precision
Develop bioorthogonal cascade-targeting methods for precise, safe, and efficient intracellular delivery of therapeutics, enhancing drug targeting and minimizing collateral damage.
Engineering lipid nanoparticles to target and escape the endosome, deliver their cargo and perform better as breast cancer therapies
This project aims to enhance LNP-mRNA nanomedicine efficacy for advanced breast cancer by improving endosomal escape through nanoscale engineering and tailored formulations.
Linker molecules convert commercial fluorophores into tailored functional probes during biolabeling
The project aims to enhance the performance of fluorescent probes by developing versatile linker compounds that improve labeling properties for biomedical applications, reducing costs and increasing reliability.
Single-Molecule Acousto-Photonic Nanofluidics
SIMPHONICS aims to develop a high-throughput, non-invasive platform for protein fingerprinting by integrating nanopore technology with acoustic manipulation and fluorescence detection.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Versatile Amplification Method for Single-Molecule Detection in Liquid BiopsyVerSiLiB aims to develop an enzyme-free amplification platform for detecting proteins and nucleic acids in liquid biopsies, enhancing cancer management through novel affinity-mediated transport. | EIC Pathfinder | € 2.994.244 | 2022 | Details |
Versatile Amplification Method for Single-Molecule Detection in Liquid Biopsy
VerSiLiB aims to develop an enzyme-free amplification platform for detecting proteins and nucleic acids in liquid biopsies, enhancing cancer management through novel affinity-mediated transport.